ClinicalTrials.gov record
18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas
ClinicalTrials.gov ID: NCT02175745
Public ClinicalTrials.gov record NCT02175745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
ClinicalTrials.gov public records Last synced May 19, 2026, 9:05 AM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
18F-FDOPA PET/CT or PET/MRI in Patients With Gliomas
Study identification
- NCT ID
- NCT02175745
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Erik Mittra
- Other
- Enrollment
- 2 participants
Conditions and interventions
Conditions
- Adult Anaplastic Ependymoma
- Adult Anaplastic Oligodendroglioma
- Adult Brain Stem Glioma
- Adult Diffuse Astrocytoma
- Adult Giant Cell Glioblastoma
- Adult Glioblastoma
- Adult Gliosarcoma
- Adult Mixed Glioma
- Adult Oligodendroglioma
- Adult Pilocytic Astrocytoma
- Adult Pineal Gland Astrocytoma
- Adult Subependymal Giant Cell Astrocytoma
- Childhood High-grade Cerebellar Astrocytoma
- Childhood High-grade Cerebral Astrocytoma
- Childhood Low-grade Cerebellar Astrocytoma
- Childhood Low-grade Cerebral Astrocytoma
- Recurrent Adult Brain Tumor
- Recurrent Childhood Anaplastic Astrocytoma
- Recurrent Childhood Anaplastic Oligoastrocytoma
- Recurrent Childhood Anaplastic Oligodendroglioma
- Recurrent Childhood Brain Stem Glioma
- Recurrent Childhood Cerebellar Astrocytoma
- Recurrent Childhood Cerebral Astrocytoma
- Recurrent Childhood Diffuse Astrocytoma
- Recurrent Childhood Fibrillary Astrocytoma
- Recurrent Childhood Gemistocytic Astrocytoma
- Recurrent Childhood Giant Cell Glioblastoma
- Recurrent Childhood Glioblastoma
- Recurrent Childhood Gliomatosis Cerebri
- Recurrent Childhood Gliosarcoma
- Recurrent Childhood Oligoastrocytoma
- Recurrent Childhood Oligodendroglioma
- Recurrent Childhood Pilomyxoid Astrocytoma
- Recurrent Childhood Protoplasmic Astrocytoma
- Recurrent Childhood Subependymal Giant Cell Astrocytoma
- Recurrent Childhood Visual Pathway Glioma
- Recurrent Childhood Visual Pathway and Hypothalamic Glioma
- Untreated Childhood Anaplastic Astrocytoma
- Untreated Childhood Anaplastic Oligoastrocytoma
- Untreated Childhood Anaplastic Oligodendroglioma
- Untreated Childhood Brain Stem Glioma
- Untreated Childhood Cerebellar Astrocytoma
- Untreated Childhood Cerebral Astrocytoma
- Untreated Childhood Diffuse Astrocytoma
- Untreated Childhood Fibrillary Astrocytoma
- Untreated Childhood Gemistocytic Astrocytoma
- Untreated Childhood Giant Cell Glioblastoma
- Untreated Childhood Glioblastoma
- Untreated Childhood Gliomatosis Cerebri
- Untreated Childhood Gliosarcoma
- Untreated Childhood Oligoastrocytoma
- Untreated Childhood Oligodendroglioma
- Untreated Childhood Pilomyxoid Astrocytoma
- Untreated Childhood Protoplasmic Astrocytoma
- Untreated Childhood Subependymal Giant Cell Astrocytoma
- Untreated Childhood Visual Pathway Glioma
- Untreated Childhood Visual Pathway and Hypothalamic Glioma
Interventions
- 18F-fluoro-dihydroxyphenylalanine Drug
- Computed tomography (CT) Procedure
- Magnetic resonance imaging Procedure
- Positron emission tomography (PET) Procedure
Drug · Procedure
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Jul 31, 2015
- Completion
- Nov 30, 2015
- Last update posted
- Mar 19, 2017
2014 – 2015
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Stanford University Hospitals and Clinics | Stanford | California | 94305 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02175745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 19, 2017 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02175745 live on ClinicalTrials.gov.